glp 1 direct to consumer Consumers' Expectations about GLP-1 Drugs Economic Impact on Food System Players GLP-1 Receptor Agonist Market Size

During the item generation and discussion and clarification phases, the experts identified 14 distinct challenges: costs, supply challenges, lack of evidence, polypharmacy, barriers to prescription, lack of knowledge, adherence concerns, aversion to injection therapy, clinical inertia, titration needs, perceived health state, fear of adverse effects, lack of clinical guideline recommendations, and lack of measurable outcomes to guide therapy

The FDA ended the official tirzepatide shortage, which restricts the legal basis for 503A pharmacies to compound it

Diabetologia 59:13671371 Lao J, Hansen BC, Dimarchi R, Pocai A (2013) Effect of GLP1R/GCGR dual agonist in monkeys

doi: 10.1002/oby.24002 [DOI] [PubMed] [Google Scholar] 5.Han SH, Safeek R, Ockerman K, et al

March 2, 2026